Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Masashi Higashi"'
Autor:
Keiji Yokoyama, Hiromi Fukuda, Ryo Yamauchi, Masashi Higashi, Takashi Miyayama, Tomotaka Higashi, Yotaro Uchida, Kumiko Shibata, Naoaki Tsuchiya, Atsushi Fukunaga, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai
Publikováno v:
Medicina, Vol 58, Iss 9, p 1276 (2022)
Background and Objectives: To investigate the long-term efficacy of rifaximin (RFX) for hyperammonemia and efficacy for refractory ascites in patients with cirrhosis. Materials and Methods: We enrolled 112 patients with liver cirrhosis who were orall
Externí odkaz:
https://doaj.org/article/62c892d174f648a584edb02acda749be
Autor:
Takashi Kuratomi, Hiroki Hayashi, Masashi Higashi, Chikara Hiramatsu, Toshiaki Irizuki, Toshihiro Takahashi
Publikováno v:
Journal of the Japanese Association for Petroleum Technology. 82:131-142
Publikováno v:
Journal of the Japanese Association for Petroleum Technology. 80:375-384
Autor:
Toshihiko Mizuta, Kunio Fujisaki, Eiji Kajiwara, Kazuhiro Sugi, Kazuhiko Nakao, Hiroshi Watanabe, Kazufumi Dohmen, Shigetoshi Fujiyama, Masashi Higashi, Toshihiro Maruyama, Michio Sata, Jun Hayashi, Shotaro Sakisaka, Yutaka Sasaki, Hiroshi Yatsuhashi, Masaru Harada, Hiromi Ishibashi, Makoto Oketani, Hirohito Tsubouchi
Publikováno v:
Kanzo. 54:266-276
Autor:
Eriko Kawaguchi, Masashi Higashi, Hiromi Yamagawa, Shiho Asano, Mitsuteru Akiba, Seiichi Kanetani, Yosuke Usui
Publikováno v:
Journal of the Japanese Forest Society. 95:253-258
Publikováno v:
Journal of Gastroenterology. 44:338-345
The rates of sustained virologic response (SVR) and relapse with pegylated interferon alpha 2b (peginterferon) plus ribavirin in patients with genotype-1 chronic hepatitis C (CHC) are approximately 50 and 30%, respectively. We investigated whether SV
Autor:
Eiji Kajiwara, Tamotsu Mukai, Hiromi Ishibashi, Masashi Higashi, Junya Shimono, Hideyuki Nomura, Nobuyuki Yamashita, Masanori Nagano, Seizaburo Kashiwagi, Hironori Tanimoto, Toshihiro Maruyama, Yutaka Matsui, Jun Hayashi
Publikováno v:
Journal of Gastroenterology and Hepatology. 19:1312-1317
Background and Aim: Interferon and ribavirin combination therapy for chronic hepatitis C produces hemolytic anemia. This study was conducted to identify the factors contributing to ribavirin-induced anemia. Methods: Eighty-eight patients with chronic
Autor:
Genji Shiraishi, Masashi Higashi, Osamu Okamoto, Youichi Kimura, Chizuko Hisano, Seizaburo Kashiwagi, Chika Morita, Hitoshi Tada, Hideyuki Nomura
Publikováno v:
Clinical Therapeutics. 18:671-679
The efficacy of interferon alfa (IFN-alpha) was evaluated in 127 hepatitis C virus-ribonucleic acid (HCV-RNA)-positive patients with chronic hepatitis C in relation to HCV-RNA levels and genotype. Patients were assigned to one of three groups. Patien
Publikováno v:
TRANSACTIONS OF THE JAPAN SOCIETY OF MECHANICAL ENGINEERS Series B. 56:2704-2711
Autor:
Hiromi Ishibashi, Masashi Higashi, Hideyuki Nomura, Ryouko Hirano, Hironori Tanimoto, Yoichiro Kashiwagi, Nobuo Tsutsumi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 37(7)
Aim: The objective of this study was to examine the efficacy and safety of low dose long-term interferon (IFN) therapy in aged patients with chronic hepatitis C genotype 1. Methods: The IFN therapy was performed in Shin-Kokura Hospital on 44 patients